![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 51, 52970-52977, December 17, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







¶
From the
Department of Pharmacology, the University of Michigan Medical School, Ann Arbor, Michigan 48109 and the
Departments of Pharmacology and Cell and Developmental Biology, Cardiovascular Biology Center, University of North Carolina, Chapel Hill, North Carolina 27599
It is established that neuronal nitric-oxide synthase (nNOS) is ubiquitylated and proteasomally degraded. The proteasomal degradation of nNOS is enhanced by suicide inactivation of nNOS or by the inhibition of hsp90, which is a chaperone found in a native complex with nNOS. In the current study, we have examined whether CHIP, a chaperone-dependent E3 ubiquitin-protein isopeptide ligase that is known to ubiquitylate other hsp90-chaperoned proteins, could act as an ubiquitin ligase for nNOS. We found with the use of HEK293T or COS-7 cells and transient transfection methods that CHIP overexpression causes a decrease in immunodetectable levels of nNOS. The extent of the loss of nNOS is dependent on the amount of CHIP cDNA used for transfection. Lactacystin (10 µM), a selective proteasome inhibitor, attenuates the loss of nNOS in part by causing the nNOS to be found in a detergent-insoluble form. Immunoprecipitation of the nNOS and subsequent Western blotting with an anti-ubiquitin IgG shows an increase in nNOS-ubiquitin conjugates because of CHIP. Moreover, incubation of nNOS with a purified system containing an E1 ubiquitin-activating enzyme, an E2 ubiquitin carrier protein conjugating enzyme (UbcH5a), CHIP, glutathione S-transferase-tagged ubiquitin, and an ATP-generating system leads to the ubiquitylation of nNOS. The addition of purified hsp70 and hsp40 to this in vitro system greatly enhances the amount of nNOS-ubiquitin conjugates, suggesting that CHIP is an E3 ligase for nNOS whose action is facilitated by (and possibly requires) its interaction with nNOS-bound hsp70.
Received for publication, June 21, 2004 , and in revised form, September 17, 2004.
* This work was supported by National Institutes of Health Grants ES08365 (to Y. O.), HL65619 (to C. P.), GM61728 (to C. P.), and DK31573 (to W. B. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Established Investigator of the American Heart Association. To whom correspondence should be addressed: Dept. of Pharmacology, University of Michigan Medical School, Medical Science Research Bldg. III, Ann Arbor, MI 48109-0632. Tel.: 734-763-5797; Fax: 734-763-4450; E-mail: osawa{at}umich.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. B. Pratt, Y. Morishima, and Y. Osawa The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts J. Biol. Chem., August 22, 2008; 283(34): 22885 - 22889. [Full Text] [PDF] |
||||
![]() |
T. Xia, C. Dimitropoulou, J. Zeng, G. N. Antonova, C. Snead, R. C. Venema, D. Fulton, S. Qian, C. Patterson, A. Papapetropoulos, et al. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3080 - H3087. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. N. Rosser, E. Washburn, P. J. Muchowski, C. Patterson, and D. M. Cyr Chaperone Functions of the E3 Ubiquitin Ligase CHIP J. Biol. Chem., August 3, 2007; 282(31): 22267 - 22277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, K. Mao, H. Zheng, X. Wang, C. Patterson, T. D. O'Connell, and Q. Liang Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury J. Biol. Chem., July 27, 2007; 282(30): 21945 - 21952. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. P. Nephew, and P. J. Gallagher Regulation of Death-associated Protein Kinase: STABILIZATION BY HSP90 HETEROCOMPLEXES J. Biol. Chem., April 20, 2007; 282(16): 11795 - 11804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Kim, C.-Y. Jang, H. D. Kim, J. Y. Lee, B.-Y. Ahn, and J. Kim Interaction of Hsp90 with Ribosomal Proteins Protects from Ubiquitination and Proteasome-dependent Degradation Mol. Biol. Cell, February 1, 2006; 17(2): 824 - 833. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |